Belgium· BE-AMP-SAM543626-00
Itulazax
A baumpollen product containing standardised allergen extract of birch pollen (betula verrucosa), flower pollen, lipophilic extract, registered in Belgium by ALK-Abello. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Baumpollen is registered in 12 of 19 countries.
Countries holding a registration under ATC V01AA05 (baumpollen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Baumpollen · ATC V01AA05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Standardised allergen extract of birch pollen (Betula verrucosa), Flower Pollen, Lipophilic Extract
- Manufacturer
- ALK-Abello
- Country
- Belgium (BE)
- ATC code
- V01AA05
- ATC class
- Baumpollen
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb3979457
- be_apb3979465
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Baumpollen in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyAlk-Prick SqAlk-Abelló Arzneimittel Gmbh
- SwitzerlandAlutard SQ Betula verrucosa
- NorwayItulazaxALK-Abelló AS
- United KingdomSilver Birch (Betula verrucosa) pollen 50HEP/ml solution for skin prick testInmunotek
- SwedenItulazax 12 SQ-Bet Frystorkad sublingual tablettMedartuum AB
- IrelandITULAZAX 12 SQ-Bet sublingual lyophilisateALK-Abello A/S
- FinlandSUBLIVAC KoivuHAL Allergy B.V.
- CanadaITULATEKALK-ABELLO A/S
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9dec8de9-c1d5-4836-9e5a-1b3febf15bfb GET /v1/drugs/9dec8de9-c1d5-4836-9e5a-1b3febf15bfb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral lyophilisate",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Itulazax",
"name_fr": "Itulazax",
"name_nl": "Itulazax",
"amp_code": "SAM543626-00",
"strengths": [
"12.7000"
],
"pack_count": 2,
"substances": [
"Standardised allergen extract of birch pollen (Betula verrucosa), Flower Pollen, Lipophilic Extract",
"Mannitol",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Tree Pollen",
"authorisation_numbers": [
"BE543626"
]
}See everything about baumpollen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.